Olink®Part of Thermo Fisher Scientific
Capture true biological insights with proven specificity. At any scale.
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join the growing global community and consortia of Olink users to empower your biomarker discovery.
Over 1,800 and growing rapidly – covering all major disease areas
Help shape the future of health research with Olink’s cutting-edge technology
Filters
Nature Communications, 2021The geometry of clinical labs and wellness states from deeply phenotyped humans
Zimmer A., Korem Y., Rappaport N. et al.
Olink Target 96
Biofabrication, 2021Bio-instructive hydrogel expands the paracrine potency of mesenchymal stem cells
Drzeniek N., Mazzocchi A., Schlickeiser S. et al.
Science Translational Medicine, 2021Plasma from patients with bacterial sepsis or severe COVID-19 induces suppressive myeloid cell production from hematopoietic progenitors in vitro
Reyes M., Filbin M., Bhattacharyya R. et al.
Olink Explore 3072/384
Cell Discovery, 2021Integrating longitudinal clinical laboratory tests with targeted proteomic and transcriptomic analyses reveal the landscape of host responses in COVID-19
Tan Y., Zhang W., Zhu Z. et al.
European Heart Journal. Acute Cardiovascular Care, 2021Predicting outcome in acute myocardial infarction: an analysis investigating 175 circulating biomarkers
Eggers K., Lindhagen L., Baron T. et al.
PLOS ONE, 2021Plasma ACE2 predicts outcome of COVID-19 in hospitalized patients
Kragstrup T., Singh H., Grundberg I. et al.
Nephrology Dialysis Transplantation, 2021Osteoprotegerin predicts cardiovascular events in patients treated with haemodialysis
Wu P., Glerup R., Svensson M. et al.
Vaccines, 2021Predictive Markers of Immunogenicity and Efficacy for Human Vaccines
Van Tilbeurgh M., Lemdani K., Beignon A. et al.
Leukemia, 2021STAT3 activation in large granular lymphocyte leukemia is associated with cytokine signaling and DNA hypermethylation
Kim D., Park G., Huuhtanen J. et al.
Neuro-Oncology Advances, 2021Plasma IL-8 and ICOSLG as prognostic biomarkers in glioblastoma
Holst C., Christensen I., Vitting-Seerup K. et al.
Scientific Reports, 2021Inflammation-related plasma protein levels and association with adiposity measurements in young adults
Klevebro S., Björkander S., Ekström S. et al.
ESC Heart Failure, 2021Proteomic profiling for detection of early‐stage heart failure in the community
Cauwenberghs N., Sabovčik F., Magnus A. et al.
Thrombosis Research, 2021Low admission protein C levels are a risk factor for disease worsening and mortality in hospitalized patients with COVID-19
Stanne T., Pedersen A., Gisslén M. et al.
Nature Metabolism, 2021Human plasma proteomic profiles indicative of cardiorespiratory fitness
Robbins J., Peterson B., Schranner D. et al.
Scientific Reports, 2021Effect of TNFα stimulation on expression of kidney risk inflammatory proteins in human umbilical vein endothelial cells cultured in hyperglycemia
Md Dom Z., Pipino C., Krolewski B. et al.
Olink Focus
Expert Review of Proteomics, 2021Proteomic signatures of inflammatory skin diseases: a focus on atopic dermatitis
Mikhaylov D., Del Duca E., Guttman-Yassky E.
Journal of Urology, 2021Cardiovascular Proteomics: A Post Hoc Analysis from a Phase II Randomized Clinical Trial Comparing GnRH Antagonist vs GnRH Agonist among Men with Advanced Prostate Cancer
Lifshitz K., Ber Y., Shenhar C. et al.
Alzheimer's & Dementia, 2021Large‐scale plasma proteomic profiling identifies a high‐performance biomarker panel for Alzheimer's disease screening and staging
Jiang Y., Zhou X., Ip F. et al.
Communications Biology, 2021A combined approach for single-cell mRNA and intracellular protein expression analysis
Reimegård J., Tarbier M., Danielsson M. et al.
Journal of the American Academy of Dermatology, 2021Scalp and serum profiling of frontal fibrosing alopecia reveals scalp immune and fibrosis dysregulation with no systemic involvement
Dubin C., Glickman J., Del Duca E. et al.
1945 publications
Items per page
1301-1320 of 1945 publications